Charles River Laboratories International (CRL) Current Assets (2009 - 2025)

Charles River Laboratories International's Current Assets history runs 17 years deep, the most recent figure standing at $1.4 billion for Q4 2025.

• In Q4 2025, Current Assets rose 3.13% year-over-year to $1.4 billion; the TTM figure through Dec 2025 stood at $1.4 billion (up 3.13% YoY), while the FY2025 annual figure was $1.4 billion, up 3.13% from the prior year.
• Current Assets for Q4 2025 stood at $1.4 billion, down from $1.5 billion in the prior quarter.
• The five-year high for Current Assets was $1.7 billion in Q1 2024, with the low at $1.3 billion in Q2 2021.
• The 5-year median for Current Assets is $1.4 billion (2023), against an average of $1.4 billion.
• The sharpest annual moves came in 2021 and 2024: Current Assets increased 17.79% in 2021, then fell 12.78% in 2024.
• Charles River Laboratories International's Current Assets stood at $1.3 billion in 2021, then increased by 12.95% to $1.4 billion in 2022, then gained by 11.79% to $1.6 billion in 2023, then fell by 12.78% to $1.4 billion in 2024, then advanced by 3.13% to $1.4 billion in 2025.
• Business Quant data shows CRL's Current Assets at $1.4 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.5 billion in Q2 2025.